Larvol Delta - SIRPant-Immunotherapeutics-Receives-FDA-Orphan-Drug-Designation-for-SIRPantM-for-the-Treatment-of-TCell-Lymphoma

SIRPant-M (SI-101) - SIRPant Immunotherap

https://www.globenewswire.com/news-release/2023/11/15/2781080/0/en/SIRPant-Immunotherapeutics-Receives-FDA-Orphan-Drug-Designation-for-SIRPant-M-for-the-Treatment-of-T-Cell-Lymphoma.html

Nov 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next